SAN Vet got approval for manufacturing an autogenous vaccine against BTV-3 for the exemptional use in Germany

28. March 2024

SAN Vet got approval for manufacturing an autogenous vaccine against Bluetongue Disease Virus serotype 3 (BTV-3) for the exemptional use in Germany.

Getting the approval for manufacturing in March, SAN Group Biotech Germany GmbH will start delivering the autogenous vaccine for the federal states Northrhine-Westfalia, Lower Saxonie, Bremen and Rhineland-Palatinate up from 15th of April. 

The use of this vaccine is limited to ruminants located in these 4 federal states only!